Modified magnesium and lipoproteins in children with attention deficite hyperactivity disorder (ADHD)

References

• Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JR. 2006. Omega-3 fatty acid status in attention- deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 75:299–308.
   PubMed Web of Science ®Google Scholar
• Bekaroğlu M, Aslan Y, Gedik Y. Değer O, Mocan H, Erduran E, Karahan C. 1996. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note. J Child Psychol Psychiatry 37:225–227.
   PubMed Web of Science ®Google Scholar
• Bourre JM. 2006. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J Nutr Health Aging 10:386–399.
   PubMed Web of Science ®Google Scholar
• CGI (Clinical Global Impressions). 1976. National Institute of Mental Health Early Clinical Drug Evaluation, Psychopharmacology Research Branch. 217–222.
   Google Scholar
• Charach G, Kaysar N, Grosskopf I, Rabinovich A, Weintraub MJ. 2009. Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data. Clin Pharmacol 49: 848–851.
   Google Scholar
• Conners CK. 1969. A teacher rating scale for use in drug studies with children. Am J Psychiatry 126:884–888.
   PubMed Web of Science ®Google Scholar
• Curtis LT, Patel K. 2008. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. J Altern Complement Med 14:79–85.
   PubMed Web of Science ®Google Scholar
• Galland L. 1991–1992. Magnesium, stress and neuropsychiatric disorders. Magnes Trace Elem 10:287–301.
   PubMedGoogle Scholar
• Häßler F, Dück A, Reis O, Buchmann J. 2007. “Alternative” pharmakologische Therapien bei ADHS. Psychopharmakotherapie 14:229–236.
   Google Scholar
• Hamer M, Stamatakis E. 2009. Physical activity and mortality in men and women with diagnosed cardiovascular disease. Eur J Cardiovasc Prev Rehabil 16:156–160.
   PubMedGoogle Scholar
• Huss M, Völp A, Stauss-Grabo M. 2010. Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems – an observational cohort study. Lipids Health Dis 24:105.
   Google Scholar
• Irmisch G, Wiechert P, Häßler F, Langemann I. 1992. Fatty acid patterns of serum lipids and the hypermotoric syndrome. Neurosciences 18:77–80.
   Google Scholar
• Kirby A, Woodward A, Jackson S, Wang Y, Crawford MA. 2010. Childrens’ learning and behaviour and the association with cheek cell polyunsaturated fatty acid levels. Res Dev Disabil 31:731–742.
   PubMed Web of Science ®Google Scholar
• Korsten-Reck U, Kromeyer-Hauschild K, Korsten K, Baumstark MW, Dickhuth HH, Berg A. 2008. Frequency of secondary dyslipidemia in obese children.Vasc Health Risk Manage 4:1089–1094.
   PubMedGoogle Scholar
• Levant B, Zarcone TJ, Fowler SC. 2010. Developmental effects of dietary n − 3 fatty acids on activity and response to novelty. Physiol Behav 101:176–183.
   PubMed Web of Science ®Google Scholar
• Mousain-Bosc M, Roche M, Polge A, Pradal-Prat D, Rapin J, Bali JP. 2006. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. Magn Res 19:46–52.
   PubMed Web of Science ®Google Scholar
• Nogovitsina OR, Levitina EV. 2007. Neurological aspects of the clinical features, pathophysiology, and corrections of impairments in attention deficit hyperactivity disorder. Neurosci Behav Physiol 37:199–202.
   PubMedGoogle Scholar
• Rucklidge JJ, Johnstone J, Kaplan BJ. 2009. Nutrient supplementation approaches in the treatment of ADHD. Expert Rev Neurother 9:461–476.
   PubMed Web of Science ®Google Scholar
• Schwartz RD, Wagner JP, Yu X, Martin D. 1994. Bidirectional modulation of GABA-gated chloride channels by divalent cations: inhibition by Ca2 + and enhancement by Mg2+. J Neurochem 62:916–922.
   PubMed Web of Science ®Google Scholar
• Sinn N. 2007. Physical fatty acid deficiency signs in children with ADHD symptoms. Prostaglandins Leukot Essent Fatty Acids 77:109–115.
   PubMed Web of Science ®Google Scholar
• Spahis S, Vanasse M, Bélanger SA, Ghadirian P, Grenier E, Levy E. 2008. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 79:47–53.
   PubMed Web of Science ®Google Scholar
• Tierney E, Conley SK, Goodwin H, Porter FD. 2010. Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome. Am J Med Genet A 152A:91 95.
   Google Scholar